Peptide Therapy Research & Guides
Evidence-based articles on peptide therapy, GLP-1 medications, longevity medicine, and personalised healthcare from Dr. Patrick Taylor, MD.
Compounded Semaglutide FDA Ban: What Patients Need to Know
Dr. Taylor breaks down the FDA's compounded semaglutide ban, what it means for telehealth GLP-1 patients, and how to protect your treatment plan going forward.
Read article →Peptide Therapy Access 2026: What Patients Must Know
Dr. Taylor cuts through the 2026 regulatory noise to explain which peptides are at risk, which are newly legitimized, and what you should do right now.
Read article →Peptide Therapy Side Effects: A Physician's Honest Guide
Dr. Taylor cuts through social media hype to give patients an evidence-based framework for evaluating peptide therapy side effects, safety, and FDA regulatory shifts.
Read article →Why GLP-1 Not Working? Genetics May Explain It
Dr. Taylor unpacks new genetic and pharmacological research to help patients understand why GLP-1 response varies — and what to do before giving up on therapy.
Read article →